Syral: Clinical Trials

6 trials sponsored by Syral, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 6

Follow Syral: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of scFOS on Increase in Stool Frequency in Constipated People
scFOS, Maltodextrin - Functional Constipation, Healthy
Not applicableCompletedSyral1862015-10-012018-10-16
Glycaemic and Insulinaemic Responses After Consumption of FOS.
Sugar, FOS - Glycaemia
Not applicableCompletedInstitut Pasteur de Lille272014-01-012015-02-02
Glycaemic and Insulinaemic Responses After Consumption of FOS.
Sugar, FOS - Glycaemia
Not applicableCompletedInstitut Pasteur de Lille502013-10-012015-02-02
Effects of scFOS on Stool Frequency in People With Functionnal Constipation
Short-chain fructo-oligosaccharides, Maltodextrin - Functional Constipation
Not applicableCompletedSyral1202012-11-012018-10-05
Digestive Tolerance of Maltitol and FOS
maltitol 85% / FOS15%, maltitol alone, maltitol 68% / FOS 32% - Digestive Tolerance in Healthy Adults
Not applicableCompletedSyral362011-09-012013-07-26
Effects of follow-on Formula Enriched on Short-chain Fructooligosaccharides (scFOS) on Immune Response in Healthy Infants
Follow-on formula supplemented with fructo-oligosaccharides, Follow-on formula enriched with placebo (maltodextrins) - Infant
Not applicableCompletedSyral602009-03-012011-04-13

Interventions

Sugars (2)  ·  maltodextrin (2)  ·  fructooligosaccharide (1)  ·  maltitol (1)

Countries

France (5)  ·  Spain (1)

Top investigators

David Gendre, MD (2)  ·  Jean-Michel Lecerf, MD (1)  ·  Robert Benamouzig, Pr (1)